Kalaiselvan R, Theis V S, Dibb M, Teubner A, Anderson I D, Shaffer J L, Carlson G L, Lal S
National Intestinal Failure Centre, Salford Royal NHS Foundation Trust, Salford, UK.
Eur J Clin Nutr. 2014 Feb;68(2):166-70. doi: 10.1038/ejcn.2013.251. Epub 2013 Dec 11.
BACKGROUND/OBJECTIVES: Chronic radiation enteritis (RE) has been reported in up to 20% of patients receiving pelvic radiotherapy and can lead to intestinal failure (IF), accounting for 3.9% of new registrants for home parenteral nutrition (HPN) in the UK annually. Our aim is to report nutritional and survival outcomes for patients with RE referred to a national IF unit.
SUBJECTS/METHODS: A retrospective study of all new admissions over a 13-year period at the Intestinal Failure Centre, Manchester, UK. Data are presented as median (range).
Twenty-three (3.8%) of 611 patients were admitted with IF secondary to RE. The primary site of malignancy was genitourinary in 17 (74%) patients. Radiotherapy was administered 9.5 (1-42) years previously. Patients underwent 2 (1-5) laparotomies prior to intestinal failure unit (IFU) admission. Twelve (52%) patients were admitted with intestinal obstruction and 11 (48%) with intractable weight loss and/or high output fistulae/stomas. Additional conditions contributing to IF were noted in 11 (48%) patients. Twenty-two (96%) patients had 2 (1-5) laparotomies prior to IFU referral. At discharge, 5 (22%) patients resumed oral diet without the need for artificial nutrition support, 3 (13%) required enteral feeding and 13 (56%) commenced HPN. The 10-year survival of the patient cohort was 48.2%.
Surgical intervention is infrequently required, whereas the majority of patients with IF secondary to RE require long-term HPN. The judicious use of surgery in selected patients, coupled with an aggressive medical strategy to detect and treat contributing factors, and optimal enteral feeding may allow a modest proportion of patients with IF secondary to RE to achieve independence from PN.
背景/目的:据报道,接受盆腔放疗的患者中高达20%会发生慢性放射性肠炎(RE),并可导致肠衰竭(IF),在英国每年家庭肠外营养(HPN)新登记患者中占3.9%。我们的目的是报告转诊至全国性肠衰竭治疗中心的RE患者的营养和生存结局。
对象/方法:对英国曼彻斯特肠衰竭中心13年间所有新入院患者进行回顾性研究。数据以中位数(范围)表示。
611例患者中有23例(3.8%)因RE继发IF入院。17例(74%)患者的原发恶性肿瘤部位为泌尿生殖系统。放疗在9.5(1 - 42)年前进行。患者在进入肠衰竭治疗单元(IFU)之前接受了2(1 - 5)次剖腹手术。12例(52%)患者因肠梗阻入院,11例(48%)因顽固性体重减轻和/或高流量瘘/造口入院。11例(48%)患者存在导致IF的其他情况。22例(96%)患者在转诊至IFU之前接受了2(1 - 5)次剖腹手术。出院时,5例(22%)患者恢复口服饮食,无需人工营养支持,3例(13%)需要肠内喂养,13例(56%)开始接受HPN。该患者队列的10年生存率为48.2%。
很少需要手术干预,而大多数RE继发IF的患者需要长期HPN。在选定患者中明智地使用手术,结合积极的医疗策略以检测和治疗相关因素,以及优化肠内喂养,可能使一小部分RE继发IF的患者实现脱离PN的独立。